Medigene AG Pre-Announces 2024 Financial Report Release
Medigene AG has announced the pre-release of its 2024 financial report, covering January 1 to December 31, 2024, set to be published online on July 31, 2025. This announcement aligns with financial reporting regulations and informs stakeholders of the timeline for detailed financial insights, which may influence investor decisions. Medigene, based in Germany, specializes in developing innovative immunotherapies for cancer treatment. Current market cap stands at €2.97M, with a year-to-date price performance of -79.50%.
Tip Ranks·